I will have to differ from your opinion on MRNA valuation. Estimated earnings for the next 4 quarters = $29.81. Estimated revenue for the same period is $23.0B. Those numbers along with their phenomenal growth rate will justify a price of much greater than $419. Wake me up when it reaches $1000.